Emerging strategies to overcome resistance to endocrine therapy for breast cancer (vol 33, pg 791, 2014)

被引：1
|
作者：
Ziauddin, M. Firdos [1 ]
Hua, Dong [2 ]
Tang, Shou-Ching [3 ,4 ]
机构：
[1] Georgia Regents Univ, Dept Surg, Div Surg Oncol, Ctr Canc, Augusta, GA 30912 USA
[2] Jiangnan Univ, Dept Oncol, Affiliated Hosp, Wuxi 214062, Peoples R China
[3] Tianjin Med Univ, Canc Inst & Hosp, Tianjin 300060, Peoples R China
[4] Georgia Regents Univ, Div Hematol Oncol, Ctr Canc, Augusta, GA 30912 USA
来源：
CANCER AND METASTASIS REVIEWS | 2014年 / 33卷 / 04期
关键词：
D O I：
10.1007/s10555-014-9508-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1127 / 1127
页数：1
相关论文
共 50 条
  • [41] Resistance to Endocrine Therapy: Are Breast Cancer Stem Cells the Culprits?
    Ciara S. O’Brien
    Sacha J. Howell
    Gillian Farnie
    Robert B. Clarke
    Journal of Mammary Gland Biology and Neoplasia, 2009, 14 : 45 - 54
  • [42] Markers of sensitivity, dependence and resistance to endocrine therapy for breast cancer
    Miller, William R.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (03) : 345 - 357
  • [43] Breast Cancer Stem Cells and Their Role in Resistance to Endocrine Therapy
    O'Brien C.S.
    Farnie G.
    Howell S.J.
    Clarke R.B.
    Hormones and Cancer, 2011, 2 (2): : 91 - 103
  • [44] Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer
    Zilli, Marinella
    Grassadonia, Antonino
    Tinari, Nicola
    Di Giacobbe, Alessia
    Gildetti, Simona
    Giampietro, Jamara
    Natoli, Clara
    Iacobelli, Stefano
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2009, 1795 (01): : 62 - 81
  • [45] Biological reprogramming in acquired resistance to endocrine therapy of breast cancer
    Aguilar, H.
    Sole, X.
    Bonifaci, N.
    Serra-Musach, J.
    Islam, A.
    Lopez-Bigas, N.
    Mendez-Pertuz, M.
    Beijersbergen, R. L.
    Lazaro, C.
    Urruticoechea, A.
    Pujana, M. A.
    ONCOGENE, 2010, 29 (45) : 6071 - 6083
  • [46] Biological reprogramming in acquired resistance to endocrine therapy of breast cancer
    H Aguilar
    X Solé
    N Bonifaci
    J Serra-Musach
    A Islam
    N López-Bigas
    M Méndez-Pertuz
    R L Beijersbergen
    C Lázaro
    A Urruticoechea
    M A Pujana
    Oncogene, 2010, 29 : 6071 - 6083
  • [47] Resistance to Endocrine Therapy: Are Breast Cancer Stem Cells the Culprits?
    O'Brien, Ciara S.
    Howell, Sacha J.
    Farnie, Gillian
    Clarke, Robert B.
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2009, 14 (01) : 45 - 54
  • [48] New strategies to overcome resistance to mammalian target of rapamycin inhibitors in breast cancer
    Vicier, Cecile
    Dieci, Maria V.
    Andre, Fabrice
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (06) : 587 - 593
  • [49] Endocrine Therapy plus Zelodronic Acid in Premenopausal Breast Cancer (vol 360, pg 679, 2009)
    Gnant, M.
    Mlineritsch, B.
    Schippinger, W.
    Luschin-Ebengreuth, G.
    Postlberger, S.
    Menzel, C.
    Jakesz, R.
    Seifert, M.
    Hubalek, M.
    Bjelic-Radisic, V
    Samonigg, H.
    Tausch, C.
    Eidtmann, H.
    Steger, G.
    Kwasny, W.
    Dubsky, P.
    Fridrik, M.
    Fitzal, F.
    Stierer, M.
    Rucklinger, E.
    Greil, R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22): : 2379 - 2379
  • [50] Endocrine resistance in metastatic breast cancer: Mechanisms and new therapeutic strategies
    Schiff, Rachel
    Veeraraghavan, Jamunarani
    Fu, Xiaoyong
    CANCER RESEARCH, 2018, 78 (13)
12345